Top compounds associated with response to LYPD2


Feature Type Standardized
Nominal ANOVA
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.11 0.0009
mRNA lapatinib gCSI pan-cancer AAC 0.19 0.0009
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC -0.1 0.001
mRNA Erlotinib gCSI pan-cancer AAC 0.16 0.006
mRNA SNX-2112 GDSC1000 pan-cancer AAC -0.079 0.009
mRNA importazole CTRPv2 pan-cancer AAC 0.098 0.01
mRNA WZ-1-84 GDSC1000 pan-cancer AAC 0.13 0.01
mRNA ML203 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA foretinib GDSC1000 pan-cancer AAC -0.08 0.01
mRNA YK 4-279 GDSC1000 pan-cancer AAC -0.089 0.02
Download CSV